A-to-I RNA editing in leukemia stem cells - set ADAR1 on the radar
A-to-I RNA editing in leukemia stem cells - set ADAR1 on the radar |
|
https://doi.org/10.18632/oncotarget.27261
Qingfei Jiang,
Raymond Diep,
and Catriona Jamieson
|
| 6047-6048 |
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma
Preclinical analysis of human mesenchymal stem cells: tumor tropism and therapeutic efficiency of local HSV-TK suicide gene therapy in glioblastoma |
|
https://doi.org/10.18632/oncotarget.27071
Lasse Dührsen,
Sophie Hartfuß,
Daniela Hirsch,
Sabine Geiger,
Cecile L. Maire,
Jan Sedlacik,
Christine Guenther,
Manfred Westphal,
Katrin Lamszus,
Felix G. Hermann,
and Nils Ole Schmidt
|
| 6049-6061 |
Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein
Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein |
|
https://doi.org/10.18632/oncotarget.27153
Hwudaurw Chen,
Earlphia Sells,
Ritu Pandey,
Edward R. Abril,
Chiu-Hsieh Hsu,
Robert S. Krouse,
Raymond B. Nagle,
Georgios Pampalakis,
Georgia Sotiropoulou,
and Natalia A. Ignatenko
|
| 6062-6078 |
Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells
Targeted photodynamic therapy treatment of in vitro A375 metastatic melanoma cells |
|
https://doi.org/10.18632/oncotarget.27221
Channay Naidoo,
Cherie Ann Kruger,
and Heidi Abrahamse
|
| 6079-6095 |
Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer
Hyperpolarized in vivo pH imaging reveals grade-dependent acidification in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27225
David E. Korenchan,
Robert Bok,
Renuka Sriram,
Kristina Liu,
Romelyn Delos Santos,
Hecong Qin,
Iryna Lobach,
Natalie Korn,
David M. Wilson,
John Kurhanewicz,
and Robert R. Flavell
|
| 6096-6110 |
Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells
Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells |
|
https://doi.org/10.18632/oncotarget.27222
Tatsuya Kawase,
Taisuke Nakazawa,
Tomohiro Eguchi,
Hirofumi Tsuzuki,
Yoko Ueno,
Yasushi Amano,
Tomoyuki Suzuki,
Masamichi Mori,
and Taku Yoshida
|
| 6111-6123 |
The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer |
|
https://doi.org/10.18632/oncotarget.27239
Manuela A. Hoffmann,
Hans-Georg Buchholz,
Helmut J. Wieler,
Thomas Höfner,
Jonas Müller-Hübenthal,
Ludwin Trampert,
and Mathias Schreckenberger
|
| 6124-6137 |
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience
Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience |
|
https://doi.org/10.18632/oncotarget.27242
Michael Merker,
Michael Torsten Meister,
Annekathrin Heinze,
Andrea Jarisch,
Jan Sörensen,
Sabine Huenecke,
Melanie Bremm,
Claudia Cappel,
Thomas Klingebiel,
Peter Bader,
and Eva Rettinger
|
| 6138-6151 |
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A |
|
https://doi.org/10.18632/oncotarget.27247
Maryam Pourmaleki,
Jonathan H. Young,
Nicholas D. Socci,
Sarah Chiang,
Marcia Edelweiss,
Yanyun Li,
Mianlei Zhang,
Lev Roshal,
Dennis S. Chi,
Klaus J. Busam,
Ingo K. Mellinghoff,
and Travis J. Hollmann
|
| 6152-6167 |
Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures
Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures |
|
https://doi.org/10.18632/oncotarget.27249
Inayatullah Shaikh,
Afzal Ansari,
Garima Ayachit,
Monika Gandhi,
Priyanka Sharma,
Shivarudrappa Bhairappanavar,
Chaitanya G. Joshi,
and Jayashankar Das
|
| 6168-6183 |
Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients
Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients |
|
https://doi.org/10.18632/oncotarget.27250
Bruna M. Sugita,
Silma R. Pereira,
Rodrigo C. de Almeida,
Mandeep Gill,
Akanksha Mahajan,
Anju Duttargi,
Saurabh Kirolikar,
Paolo Fadda,
Rubens S. de Lima,
Cicero A. Urban,
Kepher Makambi,
Subha Madhavan,
Simina M. Boca,
Yuriy Gusev,
Iglenir J. Cavalli,
Enilze M.S.F. Ribeiro,
and Luciane R. Cavalli
|
| 6184-6203 |
The predictive capability of immunohistochemistry and DNA sequencing for determining TP53 functional mutation status: a comparative study of 41 glioblastoma patients
The predictive capability of immunohistochemistry and DNA sequencing for determining TP53 functional mutation status: a comparative study of 41 glioblastoma patients |
|
https://doi.org/10.18632/oncotarget.27252
Aarash K. Roshandel,
Christopher M. Busch,
Jennifer Van Mullekom,
Joshua A. Cuoco,
Cara M. Rogers,
Lisa S. Apfel,
Eric A. Marvin,
Harald W. Sontheimer,
and Robyn A. Umans
|
| 6204-6218 |
Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide
Preferential targeting of MCL-1 by a hydrocarbon-stapled BIM BH3 peptide |
|
https://doi.org/10.18632/oncotarget.27262
Abbas Hadji,
Greta K. Schmitt,
Mathew R. Schnorenberg,
Lauren Roach,
Connie M. Hickey,
Logan B. Leak,
Matthew V. Tirrell,
and James L. LaBelle
|
| 6219-6233 |
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer |
|
https://doi.org/10.18632/oncotarget.27263
C. Andrew Boswell,
Daniela Bumbaca Yadav,
Eduardo E. Mundo,
Shang-Fan Yu,
Jennifer Arca Lacap,
Aimee Fourie-O’Donohue,
Katherine R. Kozak,
Gregory Z. Ferl,
Crystal Zhang,
Jason Ho,
Sheila Ulufatu,
Leslie A. Khawli,
and Kedan Lin
|
| 6234-6244 |
Esophageal 3D organoids of MPV17-/- mouse model of mitochondrial DNA depletion show epithelial cell plasticity and telomere attrition
Esophageal 3D organoids of MPV17-/- mouse model of mitochondrial DNA depletion show epithelial cell plasticity and telomere attrition |
|
https://doi.org/10.18632/oncotarget.27264
Manti Guha,
Satish Srinivasan,
Maura M. Sheehan,
Takashi Kijima,
Gordon Ruthel,
Kelly Whelan,
Koji Tanaka,
Andres Klein-Szanto,
Prasanna M. Chandramouleeswaran,
Hiroshi Nakagawa,
and Narayan G. Avadhani
|
| 6245-6259 |
Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations
Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations |
|
https://doi.org/10.18632/oncotarget.27265
Jun Gong,
Edik M. Blais,
Joseph R. Bender,
Michelle Guan,
Veronica Placencio-Hickok,
Emanuel F. Petricoin,
Michael J. Pishvaian,
Gary Gregory,
Richard Tuli,
and Andrew E. Hendifar
|
| 6260-6268 |
The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts
The phenanthrene derivative PJ34 exclusively eradicates human pancreatic cancer cells in xenografts |
|
https://doi.org/10.18632/oncotarget.27268
Leonid Visochek,
Dikla Atias,
Itay Spektor,
Asher Castiel,
Talia Golan,
and Malka Cohen-Armon
|
| 6269-6282 |
Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway
Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway |
|
https://doi.org/10.18632/oncotarget.27273
Zhengxiao Ouyang,
Xiaoning Guo,
Xia Chen,
Bo Liu,
Qiang Zhang,
Ziqing Yin,
Zanjing Zhai,
Xinhua Qu,
Xuqiang Liu,
Dan Peng,
Yi Shen,
Tang Liu,
and Qing Zhang
|
| 6283-6284 |
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC |
|
https://doi.org/10.18632/oncotarget.27282
Zi Wang,
Bianyin Ma,
Hui Li,
Xiaojuan Xiao,
Weihua Zhou,
Feng Liu,
Bin Zhang,
Min Zhu,
Qin Yang,
Yayue Zeng,
Yang Sun,
Shuming Sun,
Yanpeng Wang,
Yibin Zhang,
Haibo Weng,
Lixiang Chen,
Mao Ye,
Xiuli An,
and Jing Liu
|
| 6285-6285 |
